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Abstract. The discovery of several genes that affect risk for Alzheimer’s 
disease ignited a worldwide search for Single Nucleotide Polymorphisms 
(SNPs), common genetic variants that affect the brain. Genome-wide search 
of all possible SNP-SNP interactions is challenging and rarely attempted, due 
to the complexity of conducting ~1011 pairwise statistical tests. However, 
recent advances in machine learning, e.g., iterative sure independence 
screening (SIS), make it possible to analyze datasets with vastly more 
predictors than observations. Using an implementation of the SIS algorithm 
(called EPISIS), we performed a genome-wide interaction analysis testing all 
possible SNP-SNP interactions affecting regional brain volumes measured on 
MRI and mapped using tensor-based morphometry. We identified a 
significant SNP pair, rs1345203 and rs1213205, associated with temporal 
lobe volume. We mapped the whole-brain, voxelwise effects of the 
interaction in the ADNI dataset and separately in an independent replication 
dataset of healthy twins (QTIM). Each additional loading in the interaction 
effect was associated with ~5% greater brain regional brain volume (a 
protective effect) in both ADNI and QTIM samples. 
 
Keywords: epistasis, interaction, genome-wide, GWAS, GWIA, sure 
independence screening, tensor-based morphometry 
 
1. Introduction 
 
Many common brain disorders such as Alzheimer’s disease (AD), schizophrenia, and 
bipolar disorder are more prevalent in family members of those affected than in the 
population as a whole (Pedersen et al., 2004; Lichtenstein et al., 2009). If disease risk 
increases in relatives of patients, it is possible to use family studies to estimate the overall 
proportion of disease risk attributable to common or rare transmitted variants in our 
DNA; this is the concept of heritability (Neale and Cardon, 1992).  
 
However, identifying the specific DNA variants associated with increased disease risk is 
an incredibly complex task. There are over 3 billion base pairs in our DNA, and over 10 
million of these are known to have variations that are somewhat prevalent (>1%) in the 
population (Altshuler et al., 2010). Each of these variants may have a unique and often 
unknown role to play in the biology of the human body though the vast majority likely 
have no role at all. Similarly, for many brain disorders we have an incomplete 
understanding of the underlying etiology. Commonly measured clinical scores are used 
for diagnosis, but, in some cases, neuroimaging measures may offer better biomarkers of 
disease progression and severity (Jack et al., 2004; Braskie et al., 2013).  
 
The field of neuroimaging genetics uses neuroimaging biomarkers as proxies for disease 
(also called endophenotypes; Gottesman and Gould, 2003) to identify specific genetic 
variants that affect quantitative measures of brain structure or function. One goal of 
imaging genetics is to identify common genetic variants that affect the brain, positively or 
negatively, and then understand if and how any of those variations are associated with 
increased risk for developing a specific brain disease. Conversely, it is possible to use 
neuroimaging to identify the effects of Alzheimer’s disease risk genes whose function is 
not yet well understood (Braskie et al., 2011). For example, a common variant in the 
CLU gene confers a heightened risk for AD (by 10-20%) in a large sector of the 
population, although the mechanism is not known. Neuroimaging of carriers of this 
variant revealed widespread reductions in the brains’ fiber integrity around 50 years 
before the disease is typically diagnosed. Similarly, the TREM2 gene harbors rarer 
variants that elevate AD by a still greater factor, and neuroimaging has recently establish 
that carriers of the adverse variant lose brain tissue faster (Rajagopalan et al., 2013). 
 
Until recently, neuroimaging genetics studies have tended to focus on candidate genes 
such as brain-derived neurotrophic factor (BDNF; Bueller et al., 2006) and catechol-O-
methyltransferase (COMT; Egan et al., 2001). Biffi et al. (2010) looked at Alzheimer’s 
disease candidate genes APOE, CR1, and PICALM and found that each gene has 
significant effects on neuroimaging biomarkers like hippocampal volume. Candidate 
gene studies examine small subsets of gene changes chosen from the millions of variants 
in our DNA based on prior hypotheses about underlying disease pathways. However, 
many candidate gene studies have a mixed history of replication (see Supplementary 
Table 7 and 8 in Stein et al., 2012). For many candidate genes in psychiatry, although not 
so much in the dementia field, there is some level of controversy or uncertainty as to 
whether the effects are robust; very large consortia, such as the Psychiatric Genomics 
Consortium (Ripke et al., 2011) and the ENIGMA Consortium (Stein et al., 2012; 
Jahanshad et al., 2013; Hibar et al., 2013) have been set up to verify genetic effects with 
unprecedented power. In contrast, genome-wide association studies (GWAS), which 
systematically screen millions of common variants in our DNA, called single nucleotide 
polymorphisms (SNPs), have recently found a large number of replicated associations of 
genetic polymorphisms with disease, often using a hypotheses free screen of the genome 
(Harold et al., 2009). For example, Stein et al. (2012) performed a GWAS of mean 
hippocampal volume, total brain volume, and intracranial volume in 10,372 subjects for 
the Enhancing Neuro Imaging Genetics through Meta-Analysis (ENIGMA) Consortium. 
Stein et al. (2012) identified two genome-wide significant SNPs related to hippocampal 
volume rs7294919 (located in chromosome 12q24.22) and intracranial volume 
rs10784502 (located in chromosome 12q14.3). The results were independently replicated 
in another large GWAS by the Cohorts for Heart and Aging Research in Genomic 
Epidemiology (CHARGE) Consortium (Bis et al., 2012). The convergent results from the 
ENIGMA and CHARGE consortia provide evidence and replication for real genetic 
effects on hippocampal and intracranial volumes that are consistent worldwide. 
 
However, many of the reported findings from GWA studies have small effect sizes and 
explain only a small proportion of the variance estimated to be due to purely genetic 
factors. In the ENIGMA study of hippocampal volume, Stein et al. (2012) showed that 
mean hippocampal volume was 64-72% heritable, but their most significant SNP 
explained only 0.265% percent of the total observed variance in hippocampal volume. 
Similarly, height is very highly heritable (around 80%; Silventoinen et al., 2003; 
Macgregor et al., 2006), and a large GWAS of height in 183,727 subjects identified 180 
significant SNPs that collectively explain 10% of the observed variance in height (Allen 
et al., 2010). These findings have led to speculation about the source of the missing 
heritability: the proportion of variance in a trait that we know is influenced by genetics, 
but that is undetectable, so far, in the common genetic variants examined to date in GWA 
studies. Potential sources of the missing heritability might be caused by non-additive 
effects like dominance and SNP-SNP interactions (called epistasis; Carlborg et al., 2004) 
and gene-by-environment interactions (Visscher et al., 2008), and rare genetic variants 
(Manolio et al., 2009). It is also possible that deeper sequencing of the genome will 
identify causal loci with greater effects, as GWAS often genotypes only a subset of the 
common variants in the genome. Whole exome sequencing and whole genome 
sequencing, for example, are already underway for the ADNI cohort. While interaction 
testing holds promise, depending on the influence of the underlying interaction current 
statistical approaches can be underpowered (Marchini et al., 2005). Further still, some 
estimates show that interactions in regions outside of the highly polymorphic HLA region 
in the genome might not significantly improve our understanding of the problem of 
missing heritability (Clayton 2009).  In this paper we will focus our analysis on SNP-
SNP epistatic interactions. These are not well studied and some of the computational 
reasons and challenges are explained below, along with a proposed solution.  
 
Some prior studies have examined epistatic effects of SNPs on brain structure (Pezawas 
et al., 2008; Tan et al., 2007; Wang et al., 2009). Chiang et al., (2012) tested for SNP 
effects on diffusion imaging measures, and aggregated all SNPs with correlated effects 
into a network. The concept here is different, and aims to assess gene pairs that influence 
each other’s effects on the brain. None of these prior studies has considered genome-wide 
genotype data; the closest conceptually related study tested interaction effects for pre-
selected SNPs in genes and pathways already known to be related to Alzheimer’s disease 
(Meda et al., 2013). Any approach based on pre-selecting a pair of genes will overlook a 
vast search space of potential interactions among SNPs in the genome that have no 
obvious prior connection. In an interaction model, a predictor variable in the model does 
not have to be significant in order to result in a significant interaction. This is another 
way of saying that dropping non-significant SNPs from the SNP-SNP interaction search 
will miss some important interactions (Cordell, 2009). Given this, prior hypotheses 
focusing only on SNPs that have the largest known individual effects may also overlook 
large epistatic interaction effects. Intriguingly, power estimates for detecting interactive 
effects for certain models of the genetic contribution to complex traits are comparable to 
those for single SNP tests (Marchini et al., 2005). The inclusion of interaction terms was 
shown to boost the power to detect main effects in models of type 1 diabetes (Cordell et 
al., 2001). Here we examine the genome-wide, SNP-SNP ‘interactome’ to test genetic 
associations with a quantitative biomarker of Alzheimer’s disease (temporal lobe volume) 
in the publicly available Alzheimer’s Disease Neuroimaging Initiative (ADNI) dataset. 
We further examine the whole-brain effects of interaction pairs in statistical parametric 
maps generated with tensor-based morphometry (TBM); we also replicate our tests in an 
independent, non-overlapping dataset of young healthy twins from the Queensland Twin 
Imaging (QTIM) study (de Zubicaray et al., 2008). 
 
2. Methods 
 
2.1 Imaging parameters and study information 
 We downloaded the full baseline set of 818 high-resolution, T1-weighted structural MRI 
brain scans from the Alzheimer’s Disease Neuroimaging Initiative (ADNI). ADNI is a 
multi-site, longitudinal study of patients with Alzheimer’s disease (AD), mild cognitive 
impairment (MCI) and healthy elderly controls (HC). Subjects were scanned with a 
standardized protocol to maximize consistency across sites. We used the baseline 1.5 
Tesla MRI scans, i.e., the T1-weighted 3D MP-RAGE scans, with TR/TE = 2400/1000 
ms, flip angle = 8˚, slice thickness = 1.2 mm, and a final voxel resolution = 0.9375 x 
0.9375 x 1.2 mm3. Raw MRI scans were pre-processed to remove signal inhomogeneity, 
non-brain tissue, and affine registered to the MNI template (using 9 parameters). 
 
Additionally, we obtained 753 high-resolution, T1-weighted structural MRI brain scans 
from the Queensland Twin Imaging (QTIM) study. QTIM is a longitudinal neuroimaging 
and genetic study of young, healthy twins and their family members. All structural MRI 
scans were acquired on a single 4-Tesla scanner (Bruker Medspec): T1-weighted images, 
inversion recovery rapid gradient echo sequence, TR/TE = 1500/3.35 ms, flip angle = 8˚, 
slice thickness = 0.9 mm, 256 x 256 acquisition matrix, with a final voxel 
resolution = 0.9375 × 0.9375 × 0.9 mm3. Raw MRI scans were pre-processed to remove 
signal inhomogeneity, non-brain tissue, and affine registered to the ICBM template 
(using 9 parameters). 
 
2.2 Genotype pre-processing and study demographics 
 
Genome-wide genotyping data were available for the full set of ADNI subjects. We 
performed standard quality control procedures to ascertain the largest homogenous 
genetic sub-population in the dataset, using multi-dimensional scaling (MDS) compared 
to a dataset of subjects of known genetic identity (HapMap III; 
http://hapmap.ncbi.nlm.nih.gov/). The largest subset contained 737 subjects with CEU 
ancestry (i.e., Caucasians). We therefore removed the remaining 81 subjects from our 
analysis to limit the effects of genetic stratification on our statistical analyses (Lander and 
Schork et al., 1994). Additionally, we applied filter rules to the genotype data to remove 
rare SNPs (minor allele frequency < 0.01), violations of Hardy-Weinberg Equilibrium 
(HWE p < 5.7x10-7), and poor call rate (<95%). Data were further “phased” to impute 
any missing individual genotypes after filtering using the MaCH program (Abecasis et 
al., 2010) following our ENIGMA imputation protocol (ENIGMA2 Genetics Support 
Team, 2012). After filtering and phasing, 534,033 SNPs remained. 
 
All QTIM subjects were ascertained for genetic similarity, so no subjects were removed 
before analysis. All 753 subjects in the QTIM dataset clustered with the CEU population, 
in the MDS analysis. The same genotype filter rules from the ADNI dataset were applied 
to the QTIM sample’s genetic data. After filtering and phasing, 521,232 SNPs remained. 
 
After all rounds of genotype pre-processing, the ADNI sample contained 737 subjects 
(mean age±sd: 75.5±6.8 yrs; 436 males) comprised of 173 patients diagnosed with 
Alzheimer’s disease, 358 subjects with mild cognitive impairment, and 206 healthy 
elderly controls. The QTIM sample contained 753 subjects (mean age±sd: 23.1±3.0 yrs; 
286 males) and consisted of 110 monozygotic twin pairs, 147 dizygotic twin pairs, 3 
dizygotic twin trios, 143 singletons, and 87 siblings from 438 families.  
 
2.3 Tensor-based morphometric differences in the full brain 
 
We calculated information on regional brain morphometry using an elastic, nonlinear 
registration algorithm (3DMI; Leow et al., 2005; Hua et al., 2012) applied to the entire 
brain. Voxelwise volumetric differences were stored, using the Jacobian value of the 
deformation matrix obtained by nonlinearly registering a subject’s scan to a study-
specific minimum deformation template (MDT). Scans from the ADNI and QTIM 
datasets were processed and analyzed separately (using separate study-specific 
templates). The MDT for the ADNI sample is a nonlinear average of 40 age- and sex-
matched healthy elderly controls (Hua et al., 2012). The MDT for the QTIM is a 
nonlinear average of 32 age- and sex- matched, unrelated subjects (Jahanshad et al., 
2012). Nonlinear registration with 3DMI yields an interpolated 110 x 110 x 110 voxel 
statistical parametric map, where the Jacobian value at each voxel represents the 
expansion required to match the same voxel in the study-specific MDT.  
 
2.4 Genome-wide, gene-gene interaction testing 
 
The EPISIS software is an implementation of the machine-learning algorithm called sure 
independence screening (SIS) developed by Fan and Lv (2008). The SIS algorithm is a 
correlation learning method that can be applied to ultra-high dimensional datasets where 
the number of predictors p is much greater than the number of observations n. Despite the 
development of robust methods for cases where p>n (e.g., the Dantzig selector of Candes 
and Tao, 2007) the properties of the selector fail when p>>n. Fan and Lv (2008) 
developed the SIS algorithm to reduce the ultra-high dimension of p to a moderately-
sized subset, while guaranteeing that the subset still explains the maximum amount of 
variance explained by the full set of predictors. It is important to note that the SIS method 
as implemented in EPISIS is a screening method, one that looks at all possible pair 
comparisons and selects the most associated among them. This is a different statistical 
approach from methods that perform dimensionality reduction, extracting the largest 
components from a set of SNP pairs independent of their relationship with the phenotype 
(Hahn et al., 2003). 
 
We conducted an exhaustive search of association tests of genome-wide SNP-SNP 
interactions with temporal lobe volume computed by integrating the Jacobian over a 
temporal lobe ROI on the MDT (Stein et al., 2010) in the ADNI dataset using the EPISIS 
software. EPISIS utilizes the massively parallel processing available in GPGPU 
(General-purpose computing on graphics processing units) framework to test p(p-1)/2 
SNP-SNP interactions in the ADNI dataset in a feasible timeframe. We used the SIS 
algorithm with cell-wise dummy coding (CDC; Ueki and Tamiya, 2012) to reduce the 
full predictor space into a subset d of n/ln(n) interaction terms (Fan and Lv, 2008). In our 
dataset n = 737 so in this case d = 111 SNP-SNP pairs. The subset of predictors are 
chosen based on the strength of the correlation of a SNP pair with the outcome measure. 
The SNP pairs are coded into a contingency table using cell-wise dummy coding (see 
Ueki and Tamiya 2012) so that the relationship of a SNP pair with the outcome measure 
can be estimated in a single correlation test. By selecting the set of predictors with the 
greatest correlation with the phenotype, by definition that set maximizes the variance 
explained by a subset of SNPs of size d. After screening the full set of possible two-way 
SNP-SNP interactions, we applied ridge regression (Hoerl, 1962; Kohannim et al., 2011) 
to the subset of interaction terms (the multiplicative loading of each SNP-SNP pair) and 
selected significant SNP-SNP interaction terms using the extended Bayesian Information 
Criterion (EBIC; Chen and Chen, 2008) with γ = 0.5. Ridge regression with the extended 
BIC can be thought of as a “double” penalized regression, where the first step is a regular 
ridge regression where like terms are penalized in a combined model. All of the 
interaction terms are included in a single model and the terms are fit penalizing 
unimportant or correlated variables. The second step uses the Bayesian Information 
Criterion to determine which SNP pairs in the model are significant. The SNPs selected 
are themselves penalized by the parameter γ to reduce the risk of selecting false positives 
(Chen and Chen, 2008). The extended BIC does not provide P-values and classical 
significance measures, but instead provides a cut off that controls the Type 1 error rate 
and selects the most parsimonious model based on the number of predictors in a model 
and also the total error variance (see Chen and Chen, 2008). The choice of the parameter 
γ was chosen based on simulations to control the false positive rate in SNP-SNP 
interaction testing across the genome (Ueki and Tamiya, 2012). A single exhaustive 
search of the genome-wide, SNP-SNP interactome with EPISIS was completed in 7 hours 
(using one NVIDIA Tesla C2050 GPU card). 
 
2.5 Voxelwise interaction analysis and replication 
 
We tested the significant SNP-SNP interaction pair selected by ridge regression for 
association with voxelwise, regional volume differences (V) at each point, i, in the full 
brain. The association test at each voxel in the ADNI dataset followed the multiplicative 
interaction model in multiple linear regression: 
 
Vi ~ β0 + βageXage + βsexXsex + βsnp1Xsnp1 + βsnp2Xsnp2 + βsnp1,2Xsnp1*Xsnp2 + ε     (1) 
 
Additionally, we used QTIM as an independent replication sample of the top SNP-SNP 
interaction pair identified by ridge regression after EPISIS. The voxelwise association 
tests assume the multiplicative interaction model, detailed previously. Due to the family 
design of the QTIM sample, we tested associations using mixed-effects modeling as 
implemented in the R package kinship (version 1.3) in order to account for relatedness. 
 
3. Results 
 
After screening the full set of SNP-SNP interaction pairs for association with temporal 
lobe volume in the ADNI dataset, we obtained a subset 111 of SNP-SNP interaction 
pairs. Next, we applied ridge regression to the pruned subset of SNP-SNP interaction 
pairs. Using the extended BIC (γ = 0.5; Ueki and Tamiya, 2012) to estimate significance 
in our ridge regression, we identified a significant interaction between rs1345203 (located 
on chromosome 2q13) which lies in a region encoding two transcription factors 
(ELF1/CEBPB) and an intergenic SNP rs1213205 (located on chromosome 16p13.2). 
Using a linear regression model for each SNP, we found that rs1345203 explains 1.3% of 
the variance in residual temporal lobe volume (i.e. after controlling for age and sex), 
while rs1213205 explains 2.4%. Together the two SNPs explain 3.8% of the variance in 
residual temporal lobe volume, and including the interaction term, the full model explains 
5.7%. The distribution of alleles for each SNP and their interaction is given in Table 1. 
 
Table 1. The distribution of alleles for the significant SNPs and the number of subjects 
with each genotype by study. For rs1345203 the minor allele is G (in ADNI MAF = 0.19 
and in QTIM MAF = 0.14) and the major allele is A in both studies. The minor allele is A 
(ADNI MAF = 0.33 and QTIM MAF = 0.30) and the major allele is G for rs1213205. 
The association testing assumes an additive model (each subject is assigned a value 0,1,2 
based on the number of minor alleles they have at a given SNP). The interaction column 
gives the number of subjects in each category after multiplying together the minor allele 
counts of each of the SNPs.  
 
Study rs1345203 rs1213205 Interaction  
ADNI (n=737) G/G: 27 A/A: 93 2 minor alleles: 46 
 A/G: 223 G/A: 297 1 minor alleles: 79 
 A/A: 487 G/G: 347 0 minor alleles: 612 
QTIM (n=753) G/G: 5 A/A: 78 2 minor alleles: 19 
 A/G: 193 G/A: 300 1 minor alleles: 70 
 A/A: 555 G/G: 375 0 minor alleles: 664 
 We further examined the significant SNP pair, rs1345203 and rs1213205, for whole-brain 
effects in the statistical parametric maps generated using tensor-based morphometry 
(TBM). In the ADNI dataset, we found broad effects bilaterally in the temporal and 
occipital lobes (Fig. 1) after correcting for multiple tests at a 5% false discovery rate 
(FDR) using the searchlight FDR method (Langers et al., 2007).  
 
 
 
Fig. 1. Percent change map from the ADNI overlaid on the study specific template. The 
percent change map is calculated from the interaction term in the regression equation at 
each voxel. Only significant regions in the percent change map are shown after correcting 
for multiple comparisons with searchlight FDR (Langers et al., 2007) at a 5% false 
discovery rate. Images follow radiological orientation. The origin is placed at the 
Posterior-Right-Inferior corner. Cooler colors over the tissue represent tissue expansion 
(larger regional brain volume) compared to an average template. There is a clear 
‘protective’ effect of the epistatic loadings bilaterally in the temporal and occipital lobes.  
 We examined the whole-brain effects of the SNP pair on voxelwise, regional brain 
volume in the statistical parametric maps in an independent dataset (QTIM). The 
distribution of alleles for each SNP and their interaction in the QTIM sample is given in 
Table 1. In the QTIM, we identified significant effects in the left temporal lobe and along 
the border of the left frontal and occipital lobes (Fig. 2) after correction for multiple tests 
at 5% false discovery rate (FDR) using the searchlight FDR method (Langers et al., 
2007). 
 
 
 
Fig. 2. Percent change map from the QTIM sample overlaid on the study specific 
template. The percent change map is calculated from the interaction term in the 
regression equation at each voxel. Only significant regions in the percent change map are 
shown after correcting for multiple comparisons with searchlight FDR (Langers et al., 
2007) at a 5% false discovery rate. Images follow radiological orientation. The origin is 
placed at the Posterior-Right-Inferior corner. Cooler colors over the tissue represent 
tissue expansion (larger regional brain volume) compared to an average template. There 
is a clear ‘protective’ effect of the epistatic loadings in the left temporal lobe and along 
the boundary of the frontal and occipital lobe. 
 
4. Discussion 
 
The genome is incredibly complex, and statistical epistasis has been suggested as an 
appropriate model for the biological interactions among genes and protein products in 
related pathways (Moore et al., 2009; Stich et al., 2007). In addition, epistasis has been 
posited as one biologically meaningful explanation for the missing heritability observed 
for many common complex traits (Manolio et al., 2009). Following the definition of 
epistasis given by Fisher (1919), here we examined the multiplicative effect of SNP-SNP 
pairs on brain volume differences. We found that significant interaction terms explain 
additional 1.9% more variance in brain volume beyond what is already explained by the 
additive SNP terms. Considering that many single SNPs explain less than 2% of the 
variance of a complex phenotype, an additional 1.9% of the variance would go missing in 
models that only consider main effects. In our primary tests of associations with temporal 
lobe volume in the ADNI dataset, we screened 1011 possible SNP-SNP interaction pairs 
using the GPU acceleration implemented in the EPISIS software. The top 111 interaction 
pairs were selected after ranking the marginal effect of each SNP-SNP pair on temporal 
lobe volume, using an implementation of the sure independence screening (SIS) 
algorithm (Fan and Lv, 2008). We used ridge regression and the extended BIC (Chen and 
Chen, 2008) to identify a significant interaction between rs1345203 and rs1213205. We 
found significant protective effects of the SNP-SNP pair on brain morphometry in two 
independent datasets. The 3D maps in Figure 1 and 2 give the effect of the interaction 
pair on brain change determined by tensor-based morphometry (TBM). Processing 
images with TBM allows the user to make statistical comparisons of local brain shape, or 
relative brain volumes, at each location across the brain. A “protective” effect may be 
interpreted as having more brain tissue at a given voxel when a person has more copies of 
the minor alleles from the SNP pair compared to those with major alleles. 
 
There are many different methods for testing epistasis in the literature. The EPISIS 
method screens all possible SNP-SNP combinations using sure independence screening 
(SIS). The SIS algorithm examines the strength of the correlation between a SNP pair and 
the outcome variable. EPISIS, which we used in this paper, is one of several possible 
choices of tools to test for epistasis by exhaustively searching the genome; others include 
BOOST/gBOOST, epiBLASTER and BiForce. EPISIS has been favorably compared 
with two other popular programs for testing epistasis, BOOST and PLINK –fast-epistasis; 
power comparisons and simulations are published in Ueki and Tamiya (2012). There do 
appear to be similar approaches available that perform an exhaustive search (i.e. 
epiBLASTER; Kam-Thong et al., 2010). However, the main innovation and advancement 
of EPISIS is in the dummy coding statistics, which allow a user to screen interaction 
effects without worrying about sparsity in combined SNP pairs. Note that the results may 
be biased by the choice of the parameter γ which was chosen based on simulation studies 
(Ueki and Tamiya 2012). It is likely that a different choice of γ would result in additional 
significant SNP pairs (or none at all). However, we provide evidence that the chosen SNP 
pair replicates in a completely independent dataset, providing further evidence that the 
association detected with EPISIS is in fact a true effect. In this manuscript we only 
considered additive effects which is only one model for testing interactive effects. It is 
entirely possible that we have missed effects that could have been detected using a 
dominance model instead. To test both models in a full genomic search would involve a 
correction for an even greater number of statistical tests, further reducing power, but a 
dominant model could be tested post hoc. 
 
The functional relevance of the epistatic effects of the two SNPs is as yet unknown. 
However, data obtained from the UCSC Genome Browser (http://genome.ucsc.edu/) 
show that rs1345203 is located in a transcription factor gene (ELF1/CEBPB) and lies 
within a region susceptible to histone acetylation and is likely highly expressed in the cell 
(Bernstein et al., 2012). The ELF1 transcription factor is involved in IL-3 immune 
response (Reddy et al., 2000) and the CEBPB transcription factor is involved in the IL-6 
immune response (Naka et al., 2002). In addition, the rs1213205 locus lies in a region 
sensitive to DNAseI cleavage and may therefore lie in an exposed region of DNA in 
euchromatin (Bernstein et al., 2012). Loci with sensitivity to DNAseI cleavage are likely 
to effect gene expression by influencing access to downstream regulatory elements 
(Degner et al., 2012). Additional work is still required to identify precisely how these two 
SNPs might affect brain structure, and to further replicate their interaction. Specifically, 
we need to identify how changes at a given SNP are related to changes in activity in gene 
transcription or translation into protein products involved in similar biological pathways.  
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